Karo Pharma AB (publ) 0RAQ.IL Stock
61.2 SEK
{{ price }}
0.000000%
{{change_pct}}%
COUNTRY
United Kingdom
Exchange
IOB
Market Cap
16.72B SEK
LOW - HIGH [24H]
0.0000
-
0.0000 SEK
VOLUME [24H]
0 SEK
{{ volume }}
P/E Ratio
0
Earnings per share
0 SEK
Karo Pharma AB (publ) Price Chart
Karo Pharma AB (publ) 0RAQ.IL Financial and Trading Overview
| Karo Pharma AB (publ) stock price | 61.2 SEK |
| Previous Close | 61.2 SEK |
| Open | 0 SEK |
| Bid | 0 SEK x 0 |
| Ask | 0 SEK x 0 |
| Day's Range | 60.4 - 60.4 SEK |
| 52 Week Range | 49.25 - 61.2 SEK |
| Volume | 3.41M SEK |
| Avg. Volume | 0 SEK |
| Market Cap | 16.72B SEK |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 SEK |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
0RAQ.IL Valuation Measures
| Enterprise Value | N/A |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Karo Pharma AB (publ) Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 61.2 SEK |
| 52 Week Low | 49.25 SEK |
| 50-Day Moving Average | 61.2 SEK |
| 200-Day Moving Average | 60.94 SEK |
0RAQ.IL Share Statistics
| Avg. Volume (3 month) | 0 SEK |
| Avg. Daily Volume (10-Days) | 0 SEK |
| Shares Outstanding | N/A |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | N/A |
| Most Recent Quarter (mrq) | N/A |
| Next Fiscal Year End | N/A |
Profitability
| Profit Margin | N/A |
| Operating Margin (ttm) | N/A |
| Gross Margin | N/A |
| EBITDA Margin | N/A |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 1.71B SEK |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | N/A |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Q&A For Karo Pharma AB (publ) Stock
What is a current 0RAQ.IL stock price?
Karo Pharma AB (publ) 0RAQ.IL stock price today per share is 61.2 SEK.
How to purchase Karo Pharma AB (publ) stock?
You can buy 0RAQ.IL shares on the IOB exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Karo Pharma AB (publ)?
The stock symbol or ticker of Karo Pharma AB (publ) is 0RAQ.IL.
How many shares does Karo Pharma AB (publ) have in circulation?
The max supply of Karo Pharma AB (publ) shares is 273.26M.
What is Karo Pharma AB (publ) Price to Earnings Ratio (PE Ratio)?
Karo Pharma AB (publ) PE Ratio is 0.00000000 now.
What was Karo Pharma AB (publ) earnings per share over the trailing 12 months (TTM)?
Karo Pharma AB (publ) EPS is 0 SEK over the trailing 12 months.